Immunology

  1. No SARS-CoV-2 cross-neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic

    1. Julia Schwaiger
    2. Michael Karbiener
    3. Claudia Aberham
    4. Maria R. Farcet
    5. Thomas R. Kreil

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  2. SARS-CoV-2-induced humoral immunity through B cell epitope analysis and neutralizing activity in COVID-19 infected individuals in Japan

    1. Shota Yoshida
    2. Chikako Ono
    3. Hiroki Hayashi
    4. Satoshi Shiraishi
    5. Kazunori Tomono
    6. Hisashi Arase
    7. Yoshiharu Matsuura
    8. Hironori Nakagami

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike protein

    1. Duško Lainšček
    2. Tina Fink
    3. Vida Forstnerič
    4. Iva Hafner-Bratkovič
    5. Sara Orehek
    6. Žiga Strmšek
    7. Mateja Manček-Keber
    8. Peter Pečan
    9. Hana Esih
    10. Špela Malenšek
    11. Jana Aupič
    12. Petra Dekleva
    13. Tjaša Plaper
    14. Sara Vidmar
    15. Lucija Kadunc
    16. Mojca Benčina
    17. Neža Omersa
    18. Gregor Anderluh
    19. Florence Pojer
    20. Kelvin Lau
    21. David Hacker
    22. Bruno Correia
    23. David Peterhoff
    24. Ralf Wagner
    25. Roman Jerala

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Exploratory neuroimmune profiling identifies CNS-specific alterations in COVID-19 patients with neurological involvement

    1. Eric Song
    2. Christopher M. Bartley
    3. Ryan D. Chow
    4. Thomas T. Ngo
    5. Ruoyi Jiang
    6. Colin R. Zamecnik
    7. Ravi Dandekar
    8. Rita P. Loudermilk
    9. Yile Dai
    10. Feimei Liu
    11. Isobel A. Hawes
    12. Bonny D. Alvarenga
    13. Trung Huynh
    14. Lindsay McAlpine
    15. Nur-Taz Rahman
    16. Bertie Geng
    17. Jennifer Chiarella
    18. Benjamin Goldman-Israelow
    19. Chantal B.F. Vogels
    20. Nathan D. Grubaugh
    21. Arnau Casanovas-Massana
    22. Brett S. Phinney
    23. Michelle Salemi
    24. Jessa Alexander
    25. Juan A. Gallego
    26. Todd Lencz
    27. Hannah Walsh
    28. Carolina Lucas
    29. Jon Klein
    30. Tianyang Mao
    31. Jieun Oh
    32. Aaron Ring
    33. Serena Spudich
    34. Albert I. Ko
    35. Steven H. Kleinstein
    36. Joseph L. DeRisi
    37. Akiko Iwasaki
    38. Samuel J. Pleasure
    39. Michael R. Wilson
    40. Shelli F. Farhadian

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection

    1. Natalie S. Haddad
    2. Doan C. Nguyen
    3. Merin E. Kuruvilla
    4. Andrea Morrison-Porter
    5. Fabliha Anam
    6. Kevin S. Cashman
    7. Richard P. Ramonell
    8. Shuya Kyu
    9. Ankur Singh Saini
    10. Monica Cabrera-Mora
    11. Andrew Derrico
    12. David Alter
    13. John D. Roback
    14. Michael Horwath
    15. James B. O’Keefe
    16. Henry M. Wu
    17. An-Kwok Ian Wong
    18. Alexandra W. Dretler
    19. Ria Gripaldo
    20. Andrea N. Lane
    21. Hao Wu
    22. Saeyun Lee
    23. Mindy Hernandez
    24. Vanessa Engineer
    25. John Varghese
    26. Sang Le
    27. Iñaki Sanz
    28. John L. Daiss
    29. F. Eun-Hyung Lee

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Antibodies that potently inhibit or enhance SARS-CoV-2 spike protein-ACE2 interaction isolated from synthetic single-chain antibody libraries

    1. Matthew D. Beasley
    2. Sanja Aracic
    3. Fiona M. Gracey
    4. Ruban Kannan
    5. Avisa Masarati
    6. S. R. Premaratne
    7. Madhara Udawela
    8. Rebecca E. Wood
    9. Shereen Jabar
    10. Nicole L. Church
    11. Thien-Kim Le
    12. Dahna Makris
    13. Bradley K. McColl
    14. Ben R. Kiefel

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  7. A recombinant fragment of Human surfactant protein D binds Spike protein and inhibits infectivity and replication of SARS-CoV-2 in clinical samples

    1. Taruna Madan
    2. Barnali Biswas
    3. Praveen M. Varghese
    4. Rambhadur Subedi
    5. Hrishikesh Pandit
    6. Susan Idicula-Thomas
    7. Indra Kundu
    8. Sheetalnath Rooge
    9. Reshu Agarwal
    10. Dinesh M. Tripathi
    11. Savneet Kaur
    12. Ekta Gupta
    13. Sanjeev K. Gupta
    14. Uday Kishore

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Daytime variation in SARS-CoV-2 infection and cytokine production

    1. Aïssatou Bailo Diallo
    2. Laetitia Gay
    3. Benjamin Coiffard
    4. Marc Leone
    5. Soraya Mezouar
    6. Jean-Louis Mege

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes

    1. Rajendra Karki
    2. Bhesh Raj Sharma
    3. Shraddha Tuladhar
    4. Evan Peter Williams
    5. Lillian Zalduondo
    6. Parimal Samir
    7. Min Zheng
    8. Balamurugan Sundaram
    9. Balaji Banoth
    10. R.K. Subbarao Malireddi
    11. Patrick Schreiner
    12. Geoffrey Neale
    13. Peter Vogel
    14. Richard Webby
    15. Colleen Beth Jonsson
    16. Thirumala-Devi Kanneganti

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. ISG15-dependent Activation of the RNA Sensor MDA5 and its Antagonism by the SARS-CoV-2 papain-like protease

    1. GuanQun Liu
    2. Jung-Hyun Lee
    3. Zachary M. Parker
    4. Dhiraj Acharya
    5. Jessica J. Chiang
    6. Michiel van Gent
    7. William Riedl
    8. Meredith E. Davis-Gardner
    9. Effi Wies
    10. Cindy Chiang
    11. Michaela U. Gack

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 135 of 174 Next